U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes

B. De Meulder (Lyon, France), R. Tching Chi Yen (Lyon, France), C. Li (Stockholm, Sweden), A. Wheelock (Stockholm, Sweden), K. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), R. Djukjanovic (Southampton, United Kingdom), S. Wagers (Maasmechelen, Belgium), J. Riley (Stevenage, United Kingdom), V. Erpenbeck (Basel, Switzerland), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Marseille, France), S. Dahlén (Stockholm, Sweden), S. Fowler (Manchester, United Kingdom), I. Horvath (Budapest, Hungary), N. Krug (Hannover, Germany), P. Montuschi (Roma, Italy), M. Sanak (Krakow, Poland), T. Sandström (Umea, Sweden), D. Shaw (Nottingham, United Kingdom), F. Singer (Zurich, Switzerland), I. Pandis (London, United Kingdom), A. Bansal (Cambridge, United Kingdom), P. Sterk (Amsterdam, Netherlands), F. Baribaud (Springhouse, United States of America), C. Auffray (Lyon, France)

Source: International Congress 2018 – Biomarkers in COPD and asthma
Session: Biomarkers in COPD and asthma
Session type: Oral Presentation
Number: 3578
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. De Meulder (Lyon, France), R. Tching Chi Yen (Lyon, France), C. Li (Stockholm, Sweden), A. Wheelock (Stockholm, Sweden), K. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), R. Djukjanovic (Southampton, United Kingdom), S. Wagers (Maasmechelen, Belgium), J. Riley (Stevenage, United Kingdom), V. Erpenbeck (Basel, Switzerland), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Marseille, France), S. Dahlén (Stockholm, Sweden), S. Fowler (Manchester, United Kingdom), I. Horvath (Budapest, Hungary), N. Krug (Hannover, Germany), P. Montuschi (Roma, Italy), M. Sanak (Krakow, Poland), T. Sandström (Umea, Sweden), D. Shaw (Nottingham, United Kingdom), F. Singer (Zurich, Switzerland), I. Pandis (London, United Kingdom), A. Bansal (Cambridge, United Kingdom), P. Sterk (Amsterdam, Netherlands), F. Baribaud (Springhouse, United States of America), C. Auffray (Lyon, France). U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes. 3578

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The omics approach to defining endotypes and personalising treatment pathways in asthma
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


Integration at the network- and pathway level of multi-omics data from multiple anatomical locations facilitate COPD sub-phenotyping in small cohorts
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017

Integration of multi-omics datasets enables molecular classification of COPD
Source: Eur Respir J, 51 (5) 1701930; 10.1183/13993003.01930-2017
Year: 2018



Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018



High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013



Application of 'omics to uncover novel disease pathways
Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare
Year: 2013


Integration of transcriptomics and metabolomics with microbiomic data to identify host-microbiota interactions
Source: International Congress 2019 – PG16 Assessment and analysis of the lung microbiome
Year: 2019


Integrating fingerprints: molecular phenotyping of severe asthma
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015



Genetics, genomics and a systems approach to asthma
Source: Annual Congress 2008 - “Omics” and systems biology: the promise of future disease understanding
Year: 2008


A data management and analysis platform for RASP-UK multiomics clinical datasets
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021



Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
Source: Eur Respir J 2013; 42: 802-825
Year: 2013



Integrated omics predicts clinical outcomes
Source: International Congress 2014 – PG12 The omics revolution: the future of personalised medicine
Year: 2014




A label-free approach to airways disease: phenotypes, endotypes and treatable traits
Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Year: 2017


Omics analysis can provide novel biomarkers of seasonal rhinitis
Source: International Congress 2014 – PG12 The omics revolution: the future of personalised medicine
Year: 2014




Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017

Unifying candidate gene and GWAS approaches in asthma
Source: Annual Congress 2010 - Genetics of asthma
Year: 2010

Asthma endotypes: a new approach to classification of disease entities within asthma
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013


Establishment of an integrated clinical network and comprehensive data warehouse for the conduct of comparative effectiveness research in COPD
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011